Development of <sup>64</sup>Cu-NOTA-Trastuzumab for HER2 Targeting: A Radiopharmaceutical with Improved Pharmacokinetics for Human Studies

Sang‐Keun Woo(Korea Institute of Radiological and Medical Sciences), Joo Hyun Kang(Korea Institute of Radiological and Medical Sciences)
Journal of Nuclear Medicine
May 18, 2018
10.2967/jnumed.118.210294
Cited by 66

Related Papers

No related papers found

Powered by citation graph analysis